Workflow
Ocular Therapeutix™ to Report Second Quarter 2024 Financial Results on August 7, 2024
OCULOcular Therapeutix(OCUL) GlobeNewswire News Room·2024-07-31 11:30

BEDFORD, Mass., July 31, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) ("Ocular"), a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative therapies for retinal diseases and other eye conditions, today announced that it plans to host a conference call and webcast on Wednesday, August 7, 2024, at 8:00 AM ET to discuss recent business progress and financial results for the second quarter ended June 30, 2024. The ...